Will this research paper on lipid accumulation in mice be retracted?
8
Ṁ792Ṁ180
resolved Jan 4
Resolved
NO1D
1W
1M
ALL
A keen user of PubPeer has noted that key figures in the following paper may have been re-used. Specifically, Figure 3A and 7A appear to be the same.
Will this lead to the paper being retracted in 2022?
Post on PubPeer:
https://pubpeer.com/publications/15772C6EBA89AFA52F9C8DB5DB2162
The paper in question:
Cold-Pressed Nigella Sativa Oil Standardized to 3% Thymoquinone Potentiates Omega-3 Protection against Obesity-Induced Oxidative Stress, Inflammation, and Markers of Insulin Resistance Accompanied with Conversion of White to Beige Fat in Mice.
doi: 10.3390/antiox9060489 issn: 2076-3921 pubmed: 32512788
https://pubmed.ncbi.nlm.nih.gov/32512788/
Get Ṁ200 play money
🏅 Top traders
| # | Name | Total profit |
|---|---|---|
| 1 | Ṁ15 | |
| 2 | Ṁ12 | |
| 3 | Ṁ0 | |
| 4 | Ṁ0 | |
| 5 | Ṁ0 |
Related questions
Will a Biology paper containing false data generated by a LLM tool be published in an accredited journal in 2024?
49% chance
Will the Robust Mouse Rejuvenation Study by the LEVF succeed in increasing mouse lifespan 12 months?
40% chance
Will a Psychology paper containing false data generated by a LLM tool be published in an accredited journal in 2024?
52% chance
How many papers published in Nature will be retracted in 2024?
Will a currently-published paper on autogynephilia be retracted by the end of 2028?
67% chance
Will 1,3-butanediol significantly extend the lifespan of UM-HET3 mice tested by the NIA’s Interventions Testing Program? (Cohort 13: C2017)
32% chance
Will a paper falsified (or containing false data generated) by a LLM tool be published in an accredited journal in 2024?
80% chance
If the experiment in the Chinchilla paper is repeated by a credible actor before 2026, will the exponent in the data scaling term be greater than 0.32?
66% chance
Will the contaminant hypothesis of modern obesity be judged true by expert consensus before 2025?
3% chance
Will a clinical trial reporting weight-loss benefits of a GLP-1 agonist be published in a major medical journal in 2024?
82% chance